News and Activities

Hot Off The Press.

Press Releases

Proteocyte AI featured in online publication 360Dx

Toronto, ON; March 29, 2018 - Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, was recently featured in 360Dx. 360Dx covers emerging economic and technological trends in the clinical diagnostic...

read more

Today Proteocyte Diagnostics becomes…

Toronto, ON; March 9, 2018 - Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, announced a name change to Proteocyte AI, effectively immediately. “Our new corporate identity better reflects how we...

read more

New Study Shows Straticyte™ More Accurate Than Dysplasia Grading

Toronto, ON; February 2, 2017 - A newly published study shows Straticyte better defines the risk for developing oral squamous cell carcinoma than histopathological dysplasia grading alone. The study “Individualized Five-Year Risk Assessment for Oral Pre-malignant Progression to Cancer”was just...

read more

Sign up, read up, stay informed!

Join our mailing list to stay up-to-date with the latest news and activities from Proteocyte.

Thank you for subscribing to our newsletter!